Medscape31m
FDA OKs First-in-Class Antipsychotic for Schizophrenia
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.
Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...
Wall Street edges higher after inflation report; small caps outperform
U.S. main stock indexes inched up on Friday and small-cap stocks outperformed after a benign inflation report cleared the way ...
Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials
The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...
The American Journal of Managed Care50m
FDA Approves Dupilumab as First Biologic Treatment for COPD
The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary ...
BMEA Stock Up 9% as FDA Lifts Clinical Hold on 2 Diabetes Studies
Biomea stock rises 9% after the FDA lifts clinical hold on two phase I/II studies evaluating the company's lead candidate, ...
Intermountain Medical Center first to use FDA-approved device to treat complex aortic aneurysms
Intermountain Medical Center in Murray has made medical history as the first hospital in the United States to perform a new ...
verywellhealth26m
FDA Clears the First Implantable Continuous Glucose Monitor That Can Last a Year
The FDA has cleared the implantable Eversense 365 CGM, which can last up to a year without replacement. The device requires ...
ConsumerAffairs57m
Two brands of raw pet food withdrawn because of salmonella, listeria
Raw pet food is growing in popularity but can present serious health issues to pets and their owners if it becomes ...
92.7 WMAY53m
FDA approves first new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
FDA approves 1st new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb, combines ...